Three studies focused on TLR4 gene/mRNA expression in PBMCs [29,34,35], with two comparing outcomes between persons with schizophrenia on APs and HCs [34, 35] and one assessing both drug-naïve and AP-medicated individuals [29]. Here, TLR4 is linked to schizophrenia.